scholarly journals Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

2012 ◽  
Vol 27 (3) ◽  
pp. 349-356 ◽  
Author(s):  
Irene Litvan ◽  
Jennifer G. Goldman ◽  
Alexander I. Tröster ◽  
Ben A. Schmand ◽  
Daniel Weintraub ◽  
...  





2016 ◽  
Vol 4 (2) ◽  
pp. 237-244 ◽  
Author(s):  
Ondrej Bezdicek ◽  
Tomas Nikolai ◽  
Jiri Michalec ◽  
Filip Růžička ◽  
Petra Havránková ◽  
...  


2013 ◽  
Vol 28 (14) ◽  
pp. 1972-1979 ◽  
Author(s):  
Jennifer G. Goldman ◽  
Samantha Holden ◽  
Bryan Bernard ◽  
Bichun Ouyang ◽  
Christopher G. Goetz ◽  
...  


2015 ◽  
Vol 21 (2) ◽  
pp. 137-145 ◽  
Author(s):  
Andrea M. Loftus ◽  
Romola S. Bucks ◽  
Meghan Thomas ◽  
Robert Kane ◽  
Caitlin Timms ◽  
...  

AbstractA Movement Disorder Society (MDS) taskforce recently proposed diagnostic criteria for Parkinson’s disease with features of mild cognitive impairment (PD-MCI). This study first examined the prevalence and nature of PD-MCI in a non-demented cohort using the MDS criteria. Using the generic Monte Carlo simulation method developed by Crawford and colleagues (2007), this study then estimated the base rate of the representative population who would demonstrate PD-MCI due to chance alone. A total of 104 participants with idiopathic PD underwent extensive motor and neuropsychological testing at baseline and 2 years later. The Unified Parkinson’s Disease Rating Scale (UPDRS) was used to assess motor symptoms of PD and a range of established neuropsychological tests was used to assess PD-MCI in accord with MDS criteria. In accord with MDS criteria, 38% of this cohort demonstrated PD-MCI at baseline and 48% at follow-up. Of the 36 participants in the multiple-domain PD-MCI subtype at time-1, 9 (25%) demonstrated no PD-MCI at follow up. Analysis revealed that approximately 13% of the representative population would demonstrate abnormally low scores for 2 of the 9 tests used, thereby meeting MDS criteria for PD-MCI. Clinicians and researchers need to approach a single diagnosis (i.e., based on one assessment) of PD-MCI with considerable caution. (JINS, 2015, 21, 137–145)



2011 ◽  
Vol 17 (8) ◽  
pp. 621-624 ◽  
Author(s):  
P. Martinez-Martin ◽  
C. Falup-Pecurariu ◽  
C. Rodriguez-Blazquez ◽  
M. Serrano-Dueñas ◽  
F.J. Carod Artal ◽  
...  


2020 ◽  
Vol 10 (2) ◽  
pp. 729-741 ◽  
Author(s):  
Hanan Khalil ◽  
Lana M. Chahine ◽  
Junaid Siddiqui ◽  
Mehri Salari ◽  
Shaimaa El-Jaafary ◽  
...  


2015 ◽  
Vol 21 (10) ◽  
pp. 1273-1277 ◽  
Author(s):  
Nicolas Auzou ◽  
Kathy Dujardin ◽  
Roberta Biundo ◽  
Alexandra Foubert-Samier ◽  
Caroline Barth ◽  
...  


2007 ◽  
Vol 22 (16) ◽  
pp. 2314-2324 ◽  
Author(s):  
Bruno Dubois ◽  
David Burn ◽  
Christopher Goetz ◽  
Dag Aarsland ◽  
Richard G. Brown ◽  
...  


2011 ◽  
Vol 17 (3) ◽  
pp. 393-406 ◽  
Author(s):  
Alexander I. Tröster

AbstractCognitive changes of Parkinson's disease (PD) manifest earlier and are more heterogeneous than previously appreciated. Approximately one-third of patients have at least mild cognitive changes at PD diagnosis, and subtle changes might be appreciable among those at risk for PD. Executive dysfunction is the most common cognitive change, but other phenotypes exist. Pathobiologic and potential prognostic differences among cognitive phenotypes remain poorly understood. Progress in the neuropsychology, epidemiology and pathobiology of mild cognitive impairment (MCI) in PD is hampered by lack of diagnostic criteria. This study proposes preliminary research criteria for two categories of PD non-dementia cognitive impairment. (JINS, 2011,17, 393–406)



Sign in / Sign up

Export Citation Format

Share Document